Francoise Chau
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Identification of specific metabolic capacities associated with major extraintestinal pathogenic Escherichia coli lineages.
Journal: Journal of bacteriology
Published: February 27, 2026
Impact of the inoculum size on the in vivo activity of the aztreonam-avibactam combination in a murine model of peritonitis due to Escherichia coli expressing CTX-M-15 and NDM-1.
Journal: Antimicrobial agents and chemotherapy
Published: December 19, 2024
Impact of the phenotypic expression of temocillin resistance in Escherichia coli on temocillin efficacy in a murine peritonitis model.
Journal: The Journal of antimicrobial chemotherapy
Published: October 17, 2023
Variability in cell division among anatomical sites shapes Escherichia coli antibiotic survival in a urinary tract infection mouse model.
Journal: Cell host & microbe
Published: August 14, 2023
Faecal carriage of extended-spectrum β-lactamase-producing Escherichia coli in a remote region of Niger.
Journal: The Journal of infection
Published: February 06, 2023
Synergistic Activity of Pep16, a Promising New Antibacterial Pseudopeptide against Multidrug-Resistant Organisms, in Combination with Colistin against Multidrug-Resistant Escherichia coli, In Vitro and in a Murine Peritonitis Model.
Journal: Antibiotics (Basel, Switzerland)
Published: December 05, 2022
Reduced Chlorhexidine Susceptibility Is Associated with Tetracycline Resistance tet Genes in Clinical Isolates of Escherichia coli.
Journal: Antimicrobial agents and chemotherapy
Published: February 28, 2022
Evolution of fluoroquinolone-resistant Escherichia coli in the gut after ciprofloxacin treatment.
Journal: International journal of medical microbiology : IJMM
Published: June 10, 2021
Lack of association between colistin resistance and chlorhexidine reduced susceptibility in clinical isolates of Escherichia coli.
Journal: The Journal of antimicrobial chemotherapy
Published: May 09, 2021
Activity of the combination of colistin and fosfomycin against NDM-1-producing Escherichia coli with variable levels of susceptibility to colistin and fosfomycin in a murine model of peritonitis.
Journal: The Journal of antimicrobial chemotherapy
Published: March 23, 2021
Novel Chromosomal Mutations Responsible for Fosfomycin Resistance in Escherichia coli.
Journal: Frontiers in microbiology
Published: June 22, 2020
Analysis of Paradoxical Efficacy of Carbapenems against Carbapenemase-Producing Escherichia coli in a Murine Model of Lethal Peritonitis.
Journal: Antimicrobial agents and chemotherapy
Published: May 04, 2020
Last Updated: 09/26/2026